ARVINAS, INC. - Common stock, par value $0.001 per share (the "Shares") (ARVN)

268 filings reported holding ARVN - ARVINAS, INC. - Common stock, par value $0.001 per share (the "Shares") as of Q1 2025.
ARVINAS, INC. - Common stock, par value $0.001 per share (the "Shares") (ARVN) has 209 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 64,043,851 shares of 64,245,774 outstanding shares and own 100% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8,362,200 shares), BlackRock, Inc. (6,169,602 shares), CITADEL ADVISORS LLC (3,875,846 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,825,064 shares), Pfizer Inc (3,457,815 shares), RTW INVESTMENTS, LP (3,334,308 shares), Opaleye Management Inc. (1,975,000 shares), STATE STREET CORP (1,896,190 shares), Alyeska Investment Group, L.P. (1,800,000 shares), and New Leaf Venture Partners, L.L.C. (1,585,721 shares).
This table shows the top 209 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.